SHORT MINI-FUTURE - ABBOTT LABORATORIES Stock

Certificat

DE000VU13R13

Delayed Deutsche Boerse AG 04:21:59 2024-06-28 am EDT
3.89 EUR -0.77% Intraday chart for SHORT MINI-FUTURE - ABBOTT LABORATORIES
Current month-4.62%
1 month-0.25%
Date Price Change
24-06-28 3.89 -0.77%
24-06-27 3.92 +1.55%
24-06-26 3.86 +1.31%
24-06-25 3.81 -0.26%
24-06-24 3.82 0.00%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 04:21 am EDT

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Vontobel Vontobel
WKN VU13R1
ISINDE000VU13R13
Date issued 2023-01-11
Strike 146.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.12
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.28
Lowest since issue 2.27
Spread 0.04
Spread %1.02%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104.6 USD
Average target price
125.2 USD
Spread / Average Target
+19.60%
Consensus